Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
6.51
+0.11 (1.72%)
At close: Aug 13, 2025, 4:00 PM
6.40
-0.11 (-1.73%)
Pre-market: Aug 14, 2025, 8:48 AM EDT
Evolus Employees
Evolus had 332 employees as of December 31, 2024. The number of employees increased by 59 or 21.61% compared to the previous year.
Employees
332
Change (1Y)
59
Growth (1Y)
21.61%
Revenue / Employee
$837,172
Profits / Employee
-$186,732
Market Cap
421.10M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EOLS News
- 5 days ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 8 days ago - Evolus, Inc. (EOLS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Evolus Reports Second Quarter 2025 Financial Results and Provides Business Updates - Business Wire
- 14 days ago - Evolus Announces Publication of Independent Study in JAMA Dermatology Demonstrating Jeuveau® as a Top Performer Among Leading Neurotoxins - Business Wire
- 23 days ago - Evolus to Report Second Quarter Financial Results on August 5, 2025 - Business Wire
- 23 days ago - Evolus - A Slightly Risky Buy Ahead Of Q2 Earnings - Seeking Alpha
- 5 weeks ago - Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in France - Business Wire
- 2 months ago - Evolysse™ Recognized in 2025 Shape Skin Awards - Business Wire